A Look At Insperity (NSP) Valuation After Recent Share Price Rebound And HRScale Partnership Hopes

Insperity stock overview following recent performance moves

Insperity (NSP) has caught investor attention after recent share price moves, including a gain of about 4% in the past day and 6% over the past week, compared with weaker long-term returns.

See our latest analysis for Insperity.

The recent 3.99% 1 day and 6.15% 7 day share price returns contrast with a weaker long run picture, with the 1 year total shareholder return down 47.36% despite a 37.73% 90 day share price rebound. This may hint at improving sentiment after a difficult period.

If you are reassessing your watchlist after Insperity's recent move, this is a good moment to look beyond HR services and check out 20 top founder-led companies

With Insperity trading at a discount to analyst price targets and an implied gap to some intrinsic value estimates, the key question is whether this reflects undervaluation or whether the market is already pricing in future growth.

Most Popular Narrative: 20.8% Undervalued

Insperity's most followed narrative pegs fair value at $40.50 per share, compared with the recent $32.09 close. This frames the current discount as valuation-driven rather than purely sentiment-driven.

The upcoming launch of Insperity HRScale, a joint solution with Workday, targets a broader and more lucrative mid-market segment, leveraging both advanced HR technology and comprehensive services. This is expected to drive higher revenue growth and improved operating leverage as premium pricing and larger average client size become possible. Expansion and enhancement of Insperity's technology platforms, including deeper AI integration and SaaS-based HR offerings, are driving higher sales efficiency and improving productivity. This is setting the stage for scalable margin expansion and stronger EBITDA over the next several years.

Read the complete narrative.

Want to see what sits behind that confidence in higher margins and earnings recovery? The narrative leans on a detailed path for revenue growth, profitability improvement, and a future earnings multiple that assumes investors will pay up for steadier cash generation.

Result: Fair Value of $40.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this depends on healthcare costs not rising faster than Insperity can reprice contracts, as well as on the Workday partnership delivering returns that justify its multi year spend.

Find out about the key risks to this Insperity narrative.

Next Steps

After considering both the upbeat and cautious aspects of this story, it may be useful to review the underlying data yourself, decide where you stand, and then check the 3 key rewards and 2 important warning signs.

Looking for more investment ideas?

If you stop with just one stock, you risk missing other opportunities that could suit your goals, risk comfort, and income needs across different parts of your portfolio.

• Target potential mispricings by scanning 49 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect their underlying strength.
• Strengthen your income stream by reviewing 10 dividend fortresses that offer higher yields and may help balance growth focused positions.
• Dial back portfolio stress by checking 66 resilient stocks with low risk scores designed to highlight companies with more resilient profiles and lower risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com